Inhibitors of 5-Lipoxygenase

Czech version

Authors: M. Gápovský; M. Remko
Authors‘ workplace: Katedra farmaceutickej chémie Farmaceutickej fakulty Univerzity Komenského, Bratislava
Published in: Čes. slov. Farm., 2002; , 55-62
Category:

Overview

Leukotrienes are powerfizl mediators of inflammation processes. Possibilities of their biosynthesis inhibition have been intensively studied during recent two decades aiming to develop new methods of therapy of various inflammatory diseases, particularly asthma. Biosynthesis of all leukotrienes is dependent on the production of the key intermediate LTA4, Transformation of arachidonic acid to LTA4 is catalyzed by the enzyme 5-lipoxygenase and faciliated by FLAP. The present paper discusses the results of recent development of new drugs in this area.

Key words:
leukotrienes - 5-lipoxygenase - inhibition of leukotriene synthesis - zileuton

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Pharmacy Clinical pharmacology

The ACE Inhibitor Captopril in the Light of Recent Clinical Studies

Dried Milk Based Infant Formula and Its Possible Contamination with Pesticide Rssidues

Effects of Consupren, Carvedilol and BL-443 on Lactate Dehydrogenase Pattern in Tissues of Rats with Cyclosporine Nephropathy

Pharmacoeconomics in the Therapy of Peptic Ulcers

Reperfusion Injury of Cold-Preserved Rat Liver

Validation of a HPLC Method for the Determination of Dioxopromethazine and Phenylephrine in Eye Drops

The Effect of Jasminic Acid on the Production of Flavonoids by the Culture Ononis arvensis L, in vitro

Pre-Formulation Studies of a Potential Local Anaesthetic from the Group of Phenylcarbamic Acid Derivatives

Article was published in

Czech and Slovak Pharmacy

2002 Issue 2